FDA Inspection 1132019 — Bankole Johnson MD

Bankole Johnson MD — FEI 3016618502

The FDA completed an inspection of Bankole Johnson MD on October 28, 2020 in Charlottesville, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 28, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Charlottesville, VA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
751721 CFR 312.66Initial and continuing review
751821 CFR 312.64(d)Financial info
752621 CFR 312.62(a)Accountability records
756021 CFR 312.60FD-1572, protocol compliance